- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Co-founders of biotech startup uBiome charged with fraud
New York: U.S. prosecutors on Thursday charged the co-founders of uBiome Inc, a San Francisco biotechnology startup, with defrauding investors about its ability to expand clinical tests to monitor gut health and obtain reimbursements from insurers.
Zachary Apte and Jessica Richman were accused of raising more than $76 million in two fundraising rounds while misleading investors about uBiome's revenue growth and reimbursement rates, the medical community's lack of acceptance for its tests, and their reliance on a "captive" group of doctors for testing.
Apte, 36, and Richman, 46, each face more than 40 criminal counts including healthcare, securities and wire fraud, with maximum penalties totaling several hundred years in prison, the U.S. Department of Justice said. The Securities and Exchange Commission filed related civil charges.
Lawyers for the defendants did not immediately respond to requests for comment.
Thursday's charges follow uBiome's Sept. 2019 bankruptcy filing and subsequent closure. The FBI had raided uBiome's headquarters the previous April.
Founded in 2012, uBiome's business focused on testing microbiomes, located in the gut and elsewhere in the body, through such tests as Gut Explorer, SmartGut and SmartJane.
Customers could buy mail-order kits, collect samples from home, complete surveys, and get results online in a few weeks.
According to prosecutors, many tests were not clinically validated or medically necessary, and the defendants' fraudulent practices included rewarding gift cards to patients who returned samples.
Prosecutors said the fraud ran from late 2015 through early 2019, with Richman trying to stoke press interest by pretending to be younger than she was.
The defendants "turned a blind eye to compliance and pursued at all costs a path designed to bring the greatest investment in their company," Acting U.S. Attorney Stephanie Hinds in San Francisco said.
Hinds' office is also prosecuting Theranos Inc founder Elizabeth Holmes, who has pleaded not guilty to defrauding investors and patients by claiming her startup could conduct a large array of medical tests with a few drops of blood.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751